{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:53:37Z","timestamp":1791651217705,"version":"4.3.4"},"reference-count":34,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>As a group, neuroendocrine tumors (NETs) secrete many different peptide hormones, yet heretofore each NET patient is typically thought to produce at most one hormone that causes a distinct hormonal syndrome. A minority of patients have multiple hormones at diagnosis and may also develop secondary hormone secretion at a later stage.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives:<\/jats:title>\n                  <jats:p>The objectives of the study were to determine the frequency and to describe the impact of multiple and secondary hormone secretion in sporadic gasteroenteropancreatic NET patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design, Setting, and Participants:<\/jats:title>\n                  <jats:p>This was a retrospective analysis of patients (n = 972) with gasteroenteropancreatic NET treated at Uppsala University Hospital, Uppsala, Sweden. Patients with the secretion of multiple hormones at diagnosis and\/or those developing secondary hormone secretion during the disease course were identified and studied in further detail.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>In pancreatic NETs (PNETs), a total of 19 of 323 patients (6%) had secretion of multiple hormones at diagnosis, and 14 of 323 (4%) had secondary changes during the disease course. These phenomena occurred exclusively in patients with an advanced disease stage, and secondary hormones were detected in a close time span with progressive disease. Patients with secondary insulin hypersecretion had increased morbidity as well as reduced survival (P &amp;lt; .002). In contrast, multiple and secondary hormone secretion was rarely seen in NETs of the small intestine with 0 and 1 of 603 cases, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion:<\/jats:title>\n                  <jats:p>Diversity of PNET hormone secretion either at diagnosis or during the disease course occurred in a minority of patients (9.3%). These phenomena had a major impact on patient outcome both through increased morbidity and mortality. Our results support that patients with metastatic PNETs should be monitored for clinical symptoms of secondary hormone secretion during the disease course.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2015-2436","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T18:01:35Z","timestamp":1450288895000},"page":"445-452","source":"Crossref","is-referenced-by-count":75,"title":["Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumours"],"prefix":"10.1210","volume":"101","author":[{"given":"Joakim","family":"Crona","sequence":"first","affiliation":[{"name":"Departments of Medical Sciences (J.C., P.A., S.W., B.E.) Uppsala University, 75185 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olov","family":"Norl\u00e9n","sequence":"additional","affiliation":[{"name":"and Surgical Sciences (O.N., P.S.), Uppsala University, 75185 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Antonodimitrakis","sequence":"additional","affiliation":[{"name":"Departments of Medical Sciences (J.C., P.A., S.W., B.E.) Uppsala University, 75185 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Welin","sequence":"additional","affiliation":[{"name":"Departments of Medical Sciences (J.C., P.A., S.W., B.E.) Uppsala University, 75185 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"St\u00e5lberg","sequence":"additional","affiliation":[{"name":"and Surgical Sciences (O.N., P.S.), Uppsala University, 75185 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbro","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Departments of Medical Sciences (J.C., P.A., S.W., B.E.) Uppsala University, 75185 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071615004421200_B1","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35 825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"2020071615004421200_B2","doi-asserted-by":"crossref","first-page":"7798","DOI":"10.1158\/1078-0432.CCR-08-0734","article-title":"Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution","volume":"14","author":"Ekeblad","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2020071615004421200_B3","first-page":"817","article-title":"Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study","volume":"35","author":"Faggiano","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"2020071615004421200_B4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10555-011-9328-6","article-title":"Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?","volume":"31","author":"Grande","year":"2012","journal-title":"Cancer Metastas Rev"},{"key":"2020071615004421200_B5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.beem.2007.01.004","article-title":"Tumour biology and histopathology of neuroendocrine tumours","volume":"21","author":"Kloppel","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2020071615004421200_B6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","author":"Modlin","year":"2008","journal-title":"Lancet Oncol"},{"key":"2020071615004421200_B7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2005.06.002","article-title":"Endocrine tumours of the pancreas","volume":"19","author":"Oberg","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2020071615004421200_B8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1677\/erc.0.0100459","article-title":"The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut","volume":"10","author":"Ardill","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"2020071615004421200_B9","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/1097-0142(19860501)57:9<1824::AID-CNCR2820570920>3.0.CO;2-Q","article-title":"Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients","volume":"57","author":"Kloppel","year":"1986","journal-title":"Cancer"},{"key":"2020071615004421200_B10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2796.1990.tb00202.x","article-title":"Neuroendocrine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patients","volume":"228","author":"Eriksson","year":"1990","journal-title":"J Intern Med"},{"key":"2020071615004421200_B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198607033150101","article-title":"Cushing's syndrome in patients with the Zollinger-Ellison syndrome","volume":"315","author":"Maton","year":"1986","journal-title":"N Engl J Med"},{"key":"2020071615004421200_B12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM198809083191003","article-title":"Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumors","volume":"319","author":"Wynick","year":"1988","journal-title":"N Engl J Med"},{"key":"2020071615004421200_B13","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/0016-5085(90)90459-E","article-title":"Multiple hormone elevations in Zollinger-Ellison syndrome. Prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndrome","volume":"99","author":"Chiang","year":"1990","journal-title":"Gastroenterology"},{"key":"2020071615004421200_B14","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/M14-2132","article-title":"Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series study","volume":"162","author":"de Mestier","year":"2015","journal-title":"Ann Intern Med"},{"key":"2020071615004421200_B15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000335591","article-title":"ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes","volume":"95","author":"Jensen","year":"2012","journal-title":"Neuroendocrinology"},{"key":"2020071615004421200_B16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000335587","article-title":"ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors","volume":"95","author":"Falconi","year":"2012","journal-title":"Neuroendocrinology"},{"key":"2020071615004421200_B17","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00268-011-1296-z","article-title":"Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center","volume":"36","author":"Norlen","year":"2012","journal-title":"World J Surg"},{"key":"2020071615004421200_B18","volume-title":"WHO Classification of Tumours of the Digestive System","author":"Bosman","year":"2010"},{"key":"2020071615004421200_B19","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615004421200_B20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an Endocrine Society clinical practice guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615004421200_B21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2020071615004421200_B22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/EJE-14-0214","article-title":"Favorable long-term outcomes of bilateral adrenalectomy in Cushing's disease","volume":"171","author":"Osswald","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2020071615004421200_B23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/gut.43.3.422","article-title":"Prognostic factors in patients with endocrine tumours of the duodenopancreatic area","volume":"43","author":"Madeira","year":"1998","journal-title":"Gut"},{"key":"2020071615004421200_B24","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/S1470-2045(15)00186-2","article-title":"Consensus on biomarkers for neuroendocrine tumour disease","volume":"16","author":"Oberg","year":"2015","journal-title":"Lancet Oncol"},{"issue":"7523","key":"2020071615004421200_B25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13633","article-title":"Diabetes recovery by age-dependent conversion of pancreatic \u03b4-cells into insulin producers","volume":"514","author":"Chera","year":"2014","journal-title":"Nature"},{"key":"2020071615004421200_B26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI66514","article-title":"Epigenomic plasticity enables human pancreatic \u03b1 to \u03b2 cell reprogramming","volume":"123","author":"Bramswig","year":"2013","journal-title":"J Clin Invest"},{"key":"2020071615004421200_B27","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/db12-1686","article-title":"Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors","volume":"62","author":"Butler","year":"2013","journal-title":"Diabetes"},{"key":"2020071615004421200_B28","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1210\/en.2004-1576","article-title":"Minireview: transcriptional regulation in pancreatic development","volume":"146","author":"Habener","year":"2005","journal-title":"Endocrinology"},{"key":"2020071615004421200_B29","first-page":"271","article-title":"Mixed endocrine pancreatic tumors producing several peptide hormones","volume":"79","author":"Larsson","year":"1975","journal-title":"Am J Pathol"},{"key":"2020071615004421200_B30","first-page":"1349","article-title":"Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression","volume":"136","author":"Rindi","year":"1990","journal-title":"Am J Pathol"},{"issue":"5","key":"2020071615004421200_B31","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/PAS.0000000000000383","article-title":"Clinicopathologic and prognostic significance of multiple hormone expression in pancreatic neuroendocrine tumors","volume":"39","author":"Kim","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"2020071615004421200_B32","first-page":"1355","article-title":"Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors","volume":"86","author":"Hessman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615004421200_B33","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2821","article-title":"Somatic mutation of CDKN1B in small intestine neuroendocrine tumors","volume":"45","author":"Francis","year":"2013","journal-title":"Nat Genet"},{"key":"2020071615004421200_B34","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1245\/s10434-014-4351-9","article-title":"Somatic mutations and genetic heterogeneity at the CDKN1B locus in small intestinal neuroendocrine tumors","volume":"22","author":"Crona","year":"2015","journal-title":"Ann Surg Oncol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/2\/445\/16607619\/jcem0445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/2\/445\/16607619\/jcem0445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T02:30:11Z","timestamp":1594953011000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/101\/2\/445\/2810577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2015-2436","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,1]]}}}